RT Journal Article
SR Electronic
T1 Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002850
DO 10.1136/jitc-2021-002850
VO 9
IS 7
A1 Siddiqui, Bilal A
A1 Gheeya, Jinesh S
A1 Goswamy, Rohit
A1 Bathala, Tharakeswara K
A1 Surasi, Devaki Shilpa
A1 Gao, Jianjun
A1 Shah, Amishi
A1 Campbell, Matthew T
A1 Msaouel, Pavlos
A1 Goswami, Sangeeta
A1 Wang, Jennifer
A1 Zurita, Amado J
A1 Jonasch, Eric
A1 Corn, Paul G
A1 Aparicio, Ana M
A1 Siefker-Radtke, Arlene O
A1 Sharma, Padmanee
A1 Subudhi, Sumit K
A1 Tannir, Nizar
YR 2021
UL http://jitc.bmj.com/content/9/7/e002850.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.